SUMMARY
Cyclic AMP (cAMP) signaling augments synaptic transmission, but because many targets of cAMP and protein kinase A (PKA) may be involved, mechanisms underlying this pathway remain unclear. To probe this mechanism, we used optogenetic stimulation of cAMP signaling by Beggiatoa-photoactivated adenylyl cyclase (bPAC) in Caenorhabditis elegans motor neurons. Behavioral, electron microscopy (EM), and electrophysiology analyses revealed cAMP effects on both the rate and on quantal size of transmitter release and led to the identification of a neuropeptidergic pathway affecting quantal size. cAMP enhanced synaptic vesicle (SV) fusion by increasing mobilization and docking/priming. cAMP further evoked dense core vesicle (DCV) release of neuropeptides, in contrast to channelrhodopsin (ChR2) stimulation. cAMP-evoked DCV release required UNC-31/Ca 2+ -dependent activator protein for secretion (CAPS). Thus, DCVs accumulated in unc-31 mutant synapses. bPAC-induced neuropeptide signaling acts presynaptically to enhance vAChT-dependent SV loading with acetylcholine, thus causing increased miniature postsynaptic current amplitudes (mPSCs) and significantly enlarged SVs.
INTRODUCTION
Neurotransmitter release is an intricate and conserved process [1, 2] . After synthesis, transport to the neuronal terminal, and fusion with the plasma membrane (PM), mature synaptic vesicles (SVs) are generated at endosomal compartments [3, 4] . SVs are then filled with transmitter, translocated to the PM, and docked/ primed at the active zone (AZ) membrane scaffold, called dense projection (DP) or presynaptic cytomatrix [5, 6] . After depolarization and Ca 2+ entry into the terminal, primed SVs (readily releasable pool [RRP] ) fuse with the PM, releasing transmitter in distinct quanta, defined by the amount of transmitter loaded into the SV. Finally, SV membrane and proteins are endocytosed and SVs are regenerated from endosomal compartments [3, 4, [7] [8] [9] . SVs can also be stored in the reserve pool by tethering them to the cytoskeleton and to each other via synapsin [10] .
To support high rates of transmitter release, the reserve pool can be mobilized by PKA-and CaMKI-dependent synapsin phosphorylation [11, 12] . Neurons adapt to different activity regimes by modulating not only rates of SV recycling, mobilization, and priming but also their quantal size [13, 14] . Such mechanisms depend on intra-and extracellular Ca 2+ [14, 15] . During sustained activity, elevated cytosolic Ca 2+ may induce secretion of dense core vesicles (DCVs) via protein kinase C (PKC) signaling [16, 17] . Additional modulatory pathways depend on cyclic AMP (cAMP) and PKA [18, 19] via phosphorylation of synaptic targets, e.g., synapsin [20] , tomosyn [21] , Rim1 [22] , ryanodine receptor (RyR) [23] , cysteine string protein [24] , snapin [25] , complexin [26] , and SNAP-25 [27] . cAMP further affects SV release via exchange protein activated by cyclic AMP (EPAC) [18] . Release of neuropeptides from DCVs requires the Ca 2+ -dependent activator protein for secretion (CAPS)/UNC-31 protein [28, 29] . Neuropeptides can affect signaling by fast neurotransmitters [30] , e.g., by providing presynaptic feedback regulation. One study suggested a signaling network by which neuropeptides potentiate the same terminal's SV release machinery via G-protein coupled receptor (GPCR)/Ga s /PKA pathways [31] . Another study suggested that PKA signaling directly affects neuropeptide release via phosphorylation of an unknown substrate, in parallel to, or alternatively activated by, UNC-31/CAPS [32] . To explore this and to distinguish postsynaptic from presynaptic effects of PKA and DCV signaling in neurotransmission, specific and acute stimulation of cAMP pathways is required.
Optogenetic stimulation of SV release via channelrhodopsin (ChR2) allows analyzing molecular pathways of neurotransmission [33, 34] and, combined with electron microscopy (EM), enables tracking of activity-induced synaptic membrane dynamics [9, 35] . Photoactivated adenylyl cyclases (PACs) are optogenetic tools for acute cAMP generation [36, 37] . Stimulation of Euglena (EuPACa) or Beggiatoa PAC (bPAC) increased cAMP concentration in HEK293 cells, Xenopus oocytes, and Drosophila. EuPACa activation in C. elegans motor neurons increased transmitter release and aroused locomotion [38] . Compared to EuPACa, bPAC has minute dark activity, a 300-fold light/dark activity increase, and is one-third the size.
Here, we used bPAC photoactivation to acutely generate cAMP in C. elegans cholinergic motor neurons. The resulting exaggerated yet coordinated movement indicated enhanced acetylcholine (ACh) output without overriding intrinsic activity (unlike ChR2 stimulation). We studied the ultrastructure of bPAC-stimulated synapses by EM following high-pressure freezing (HPF-EM). cAMP increase caused depletion and redistribution of SVs and DCVs. In contrast, DCV release was not observed following ChR2 stimulation. bPAC activation increased miniature postsynaptic current (mPSC) rate and amplitudes; the latter was not observed during ChR2 stimulation. mPSC amplitude increase required UNC-31/CAPS, suggesting that neuropeptidergic signaling controls quantal content. Indeed, released neuropeptides increased SV content and size via the vesicular ACh transporter (vAChT).
RESULTS

Photoactivation of bPAC in Cholinergic Neurons Enhances Motor Output
We expressed bPAC::YFP in cholinergic neurons ( Figure 1A ) and analyzed whether photoactivation affects locomotion, as EuPACa did earlier [38] . In dark, animals expressing bPAC behaved like wild-type (WT) controls in terms of crawling speed but with reduced mean body bending angle ( Figures 1B and 1C) . During bPAC photoactivation, animals reacted with a significant speed increase (peak during 3-8 s of light; Figure 1B ), returning to basal levels after $15-20 s. This was accompanied by a steady increase in bending angles (up to 25%; Figure 1C ; Movie S1). Bending angles remained elevated for $35 s after light offset ( Figure S1A ). bPAC photoactivation also increased swimming locomotion ( Figure S1B ; Movie S2), relapsing within 10 s after light offset. bPAC activation induced mild ($2%) body contraction during the last 10 s of photoactivation ( Figure 1D ), most likely due to increased muscle tone, lasting $25 s after light offset (not shown).
Locomotion of bPAC-stimulated animals was exaggerated but coordinated, indicating that the motor program was uncompromised. This contrasts the strong stimulation induced by ChR2(H134R) (''ChR2,'' unless otherwise noted), which depolarizes neurons and causes spastic paralysis (Movie S3) [9, 33] . bPAC-photostimulated animals resembled Ga s gainof-function (gf) mutants, which have high cAMP levels and are coordinated but hyperactive [39] . To verify that bPAC effects were caused by cAMP production, we used constitutively active phosphodiesterase in neurons. The truncated PDE-4D enzyme reduces cAMP levels [40] , leading to largely reduced basal crawling speed. In dark, bPAC; PDE(gf) animals behaved like the PDE(gf) strain ( Figures S1C and S1D ). Upon photoactivation of bPAC, PDE(gf) animals displayed a small, transient change in bending angles and a speed increase. Though these behaviors did not match WT, they demonstrate counteracting of bPAC and PDE(gf). We also analyzed adenylyl cyclase(gf) animals (constantly elevated cAMP; Figures S1E-S1H). acy-1(ce2) mutants showed slightly increased bending angles and body bends per time, as well as reduced body length, most likely due to increased muscle tone. However, they exhibited no difference in speed, indicating partial adaptation to cAMP and emphasizing the need for acute cAMP manipulation to probe rapid modulatory effects.
bPAC Activation Does Not Depolarize Neurons per se bPAC-mediated neuronal stimulation may be due to increased SV priming, causing more transmitter output whenever the neuron depolarizes. Alternatively, cAMP increase could cause mild depolarization or may evoke release independent of depolarization. To distinguish this, we coexpressed bPAC with the light-driven hyperpolarizing H + -pump MAC [41] in cholinergic cells ( Figure 1E ), enabling light control of cAMP and hyperpolarization. Stimulation of bPAC alone (animals cultivated without the MAC chromophore all-trans retinal [ATR]) led to mild contraction and speed increase ( Figures 1F and 1G) . In animals expressing MAC only, mild photoactivation increased body length and slowed locomotion, due to reduced ACh release. Neither phenotype could be reversed by bPAC co-activation (in animals coexpressing bPAC/MAC, raised with ATR). Thus, bPAC effects require depolarization. Conversely, depolarization-evoked synaptic release was enhanced by bPAC activation. The ChR chimera C1V1(E122T; E162T) [42] can be activated independently of bPAC due to its red-shifted spectrum ( Figure S1I ). Low-intensity yellow or blue light did not elicit body contraction in C1V1-ETET or bPAC animals, respectively ( Figure S1J ). However, blue-yellow co-activation of the two actuators caused significant contraction. In sum, modulatory effects evoked by bPAC/cAMP enhance the output of depolarized neurons.
bPAC Stimulation Promotes SV Release and Endocytosis of Large Vesicles Ultrastructural correlates of fast and slow synaptic events can be revealed by combining optogenetic stimulation and HPF-EM [9, 35] . bPAC/cAMP-induced increase in locomotion may be due to increased mobilization, priming, or release of SVs. We thus examined synaptic terminals by HPF-EM, following bPAC stimulation. Young adult worms were illuminated continuously for 5, 30, or 300 s and then fixed by HPF, $4 to 5 s after photostimulation (delay due to manual sample insertion). Because effects of bPAC/cAMP on behavior were long lasting, we expected to capture ultrastructural alterations even after this period. Cross sections (40 nm) of cholinergic en passant motor synapses in the ventral nerve cord were analyzed by transmission EM ( Figures  2A and 2B ). Structural features were outlined and their shapes, dimensions, and location digitized ( Figure 2C ). Morphologically docked (primed, fusion-competent) SVs were analyzed throughout the synapse. In C. elegans, docked SVs can fuse at all distances to the DP [35] . Docked SV counts were normalized to the profile perimeter (synapse size was not uniform; In addition to SV depletion, we observed large vesicles (LVs) that increased in number after photostimulation (by $150% after 5 s and $325% after 300 s; Figure 2F ). LVs had a bilayer membrane and clear core ( Figure S2C ) and resembled bulk endosomes, previously observed after ChR2 photoactivation (''100 nm vesicles'') [9] . The mean maximal diameter of bPAC-induced LVs was $64 nm ( Figure S2D ). Thus, continuous SV release during ongoing bPAC activation triggers bulk endocytosis/LV formation. bPAC versus ChR2 stimulation had different behavioral effects. To assess possible ultrastructural correlates of this difference, we also analyzed two types of ChR2-depolarized neurons: (1) cells expressing ChR2(C128S), a ''slow'' channel variant that remains open after termination of light stimulation [43] , enabling brief stimulation periods until HPF (1 s light plus 8 s sustained activity), as for 5 s bPAC stimulation (i.e., 5 s light plus 4 s of persisting bPAC activity) [37] , and (2) cells expressing ChR2(H134R) for 30 s stimulation. Both ''1+8'' and 30 s ChR2 stimulation caused significant depletion of docked SVs (by $70% and $32% of the unstimulated control, respectively; 5 and 30 s bPAC stimulation reduced them by $60%; Figures 2D and 2H) . Decreases in SV density were observed for ChR2 and bPAC stimulation and were comparable for short and long stimulations ($30%-60%; Figures 2E and 2I ). In addition, LV generation was induced by both types of stimuli ( Figures 2F, 2J , S2C, and S2D), though to a lower extent by bPAC, suggesting that bPAC stimulation is less vigorous. These differences probably do not underlie the different ChR2-and bPAC-stimulated behaviors.
cAMP Increase Facilitates SV Redistribution throughout the Nerve Terminal Next, we assessed docked SV distribution along the PM as a function of bPAC stimulation ( Figures 3A and 3B ). If SV priming and fusion is facilitated by cAMP, docked SVs should become depleted. Without stimulation, $50% of docked SVs were localized within 132 nm from the DP, as observed in WT [44] . Docked SVs were found up to $700 nm from the DP with decreasing frequency. bPAC stimulation depleted docked SVs throughout the AZ ( Figure 3B ). Reduction was significant already after 5 s at 132-165 nm from the DP. After 30-300 s bPAC stimulation, docked SVs were significantly reduced also more proximal and more distal to the DP, whereas docked SVs directly at the DP (0-33 nm) were never significantly depleted. Contrarily, following 1+8 s ChR2(C128S) stimulation, docked SVs were depleted also there ( Figure S2E ). This difference requires further investigation.
We also analyzed SV distribution throughout the terminal after bPAC stimulation (shortest linear distance of every SV, excluding docked SVs, to the DP; Figures 3C, 3D , and S2F for ChR2(C128S) stimulation). After 5 s and 300 s, SVs at %264 nm from the DP were significantly reduced, whereas at 30 s, SV distribution was reduced only in the 133-198 nm bins. An empirical cumulative distribution function (eCDF) (Figure 3E) analysis of the summed SV to DP distances per profile shows two distributions after 5 s, i.e., $40% contained SVs closer to and $60% contained SVs further from the DP. After 30 s, SV distribution (and number; Figure 2E ) was more similar to unstimulated controls, possibly due to SV recycling, with most profiles displaying SVs closer to the DP. After 300 s, SVs were overall depleted and translocated toward the DP. Therefore, SVs close to the DP may be immediately used to refill the RRP, followed by mobilization of reserve SVs and recycling, thus replenishing SVs close to the DP. 300 s stimulation depletes SVs all over the terminal and causes formation of endocytic LVs ( Figures S2C and S2D) .
bPAC-Mediated, but Not ChR2-Mediated, Stimulation Triggers DCV Release Cholinergic synapses store SVs as well as neuropeptidecontaining DCVs. By EM analysis, bPAC, but not ChR2, stimulation significantly reduced overall DCV numbers ( Figures  2G and 2K) , indicating release of neuropeptides in bPACstimulated animals. We investigated this more directly in vivo. NLP-21 is a neuropeptide precursor expressed in cholinergic neurons. When NLP-21::Venus is expressed, Venus is copackaged into DCVs and secreted to be then endocytosed from the body fluid by coelomocytes [16] (Figure 4A ). Thus, coelomocyte fluorescence reports preceding DCV release. Animals coexpressing bPAC and NLP-21::Venus in cholinergic neurons were stimulated for 30 min, and coelomocyte fluorescence was quantified ( Figures 4B and 4C) . bPAC stimulation significantly increased fluorescence $4.5-fold, which was neither observed in WT nor in animals expressing ChR2(C128S) in cholinergic cells ( Figure 4C ), consistent with EM data.
UNC-31/CAPS Is Required for bPAC-Induced DCV Release
To assess requirements for bPAC-induced DCV release, we analyzed unc-31(n1304)/CAPS mutants [28] , which cannot exocytose DCVs. In the NLP-21::Venus secretion assay, no DCV release occurred following bPAC stimulation in unc-31 mutants ( Figure 5A) . At the EM level, unc-31 mutant synapses contained more DCVs (Figures 5B and 5C ), most likely due to impaired DCV release. DCVs accumulated more in synaptic profiles flanking the DP-containing sections. bPAC stimulation did not induce DCV depletion in unc-31 mutants, whereas SVs were released ( Figure 5D ). NLP-21::Venus fluorescence accumulated in unc-31 neuron somata and processes ( Figures 5E and 5F ). Photostimulation (15 min) caused an increase of signal in WT processes, whereas in unc-31, it remained unchanged ( Figure 5G ). In sum, bPAC/cAMP stimulation of neuropeptide secretion requires UNC-31/CAPS.
bPAC Photoactivation Increases Rate and Amplitude of Cholinergic Neuron-Induced mPSCs
To correlate these findings with physiological effects of ChR2 and bPAC photoactivation, we recorded patch-clamped body wall muscle cells and compared mPSCs (corresponding to single SV fusions), as well as photoevoked PSCs, between bPAC-and ChR2-expressing animals ( Figures 6A and 6B) . bPAC photoactivation significantly increased mPSC rate (from 31.4 ± 5.5 to 42.7 ± 6.3 s À1 ; Figures 6C and 6D) . In contrast, ChR2-induced depolarization caused large photo-excitatory postsynaptic currents (EPSCs) ($1,250 pA), resulting from simultaneous fusion of many if not all primed SVs, followed by mPSCs at increased rate (from 46.0 ± 4.9 to 63.2 ± 2.8 s À1 ). Mean mPSC amplitudes before and after bPAC photoactivation (15.1 ± 2.0 versus 15.1 ± 2.1 pA) did not differ significantly from non-transgenic WT (16.7 ± 1.3 pA) and did not change in ChR2-stimulated synapses before and during light stimulation ( Figures 6E and 6F) . However, bPAC photostimulation significantly increased mean mPSC amplitudes to 19.2 ± 2.5 pA ( Figure 6F ). More 20-40 pA events were observed during bPAC photostimulation than before or after, whereas for ChR2, smaller-amplitude events were more numerous during and after photostimulation (cumulative distribution; Figures 6G and 6H) . As C. elegans muscles also receive input from GABAergic neurons (which are innervated by cholinergic neurons), we probed the observed effects for a GABA component. In unc-47(e307) mutants, lacking the vesicular GABA transporter, mPSC amplitudes and rates were reduced ( Figures 6D and 6F ), but their relative increase was alike in bPAC-stimulated WT versus unc-47(e307) animals ( Figure S3 ). Elevated cAMP levels in the acy-1(gf) mutant increased mPSC rate, but not amplitude ( Figures 6D and 6F ), indicating that the latter effect of cAMP adapts in the long term. bPAC photoactivation increases SV fusion probability in cholinergic motor neurons, leading to higher PSCs per fusion event with no GABAergic contribution. Because bPAC stimulation increased mPSC amplitudes, we probed the involvement of co-evoked neuropeptide release. unc-31(n1304)/CAPS mutants exhibited reduced basal mPSC rate ( Figures 6D and 6I) . bPAC stimulation increased mPSC rate also in unc-31 mutants; however, mPSC amplitudes were unchanged ( Figures 6F and 6J) . Thus, DCV release contributes to bPAC/cAMP-mediated transmission and bPAC-induced neuropeptide release may underlie the mPSC amplitude increase.
Presynaptic cAMP Signaling Does Not Affect Postsynaptic nAChRs
How could DCV release cause increased mPSC amplitudes? Neuropeptides may act on postsynaptic nAChRs to reduce their desensitization or to alter their mobility, thus localizing them in register with SV release sites; alternatively, neuropeptides may act presynaptically (Figures 7A and 7B ). To assess postsynaptic effects, we puff applied ACh to the neuromuscular junction (NMJ) during or after bPAC photostimulation. Synapses exhibited the expected increase in bPAC-evoked mPSC amplitudes before ACh application ( Figure S4A ). Yet, bPAC-evoked neuropeptide release did not facilitate ACh-evoked currents ( Figures 7C and 7D) in either WT or unc-17 (vAChT) mutants (to exclude that bPAC-induced ACh release could desensitize nAChRs). The NMJ uses two different nAChRs: levamisole-sensitive L-AChRs desensitize slowly and have small peak currents, whereas nicotine-sensitive N-AChRs exhibit large peak currents and fast desensitization [45] . Also, levamisole-induced PSCs were unaffected by bPAC stimulation ( Figure 7E ). To assess nAChR desensitization, we calculated ratios of puff-evoked current after 1 s to the peak current (unaltered upon bPAC stimulation; Figure 7F ) and also by analyzing the kinetics of spontaneous mPSC events: had nAChRs approximated SV release sites, their time to peak should decrease; however, it rather increased, consistent with unchanged distance but larger ACh amount (Figure S4B) . We also analyzed the t off and t on rates of nAChRs based on single mPSC events. Individual mPSCs were aligned (single and mean traces: Figures S5A and 7G, respectively) , and t off was analyzed for each mPSC and averaged for mPSCs of each trace: there was no difference between WT and unc-31/CAPS mutants ( Figures 7G and S5B for t on ) . Finally, GABA did not influence ACh-evoked currents during bPAC photostimulation (unaltered in unc-47 vGAT mutants; Figure 7D ). In sum, neuropeptides do not act postsynaptically to affect mPSC amplitude.
cAMP Signaling Induces Release of Neuropeptides that Act Presynaptically to Increase SV Filling Neuropeptides may affect mPSC amplitudes presynaptically by inducing SV filling ( Figure 7B ), i.e., serving as feedback (or modulatory) signal to increase the function of vAChT or vATPase (acidification of SVs, driving vAChT). This would enable regulation of SV content within the $3 s lag period before increased mPSC amplitudes became apparent during bPAC stimulation. To probe SV acidification as a mechanism, we acutely inhibited vATPase using bafilomycin A1 (BafA1) [18, 46] . Drug (or vehicle) was applied to the dissected preparation (6-8 min) and then cells were patch clamped and mPSCs recorded ( Figure 7H ). BafA1 reduced mPSC rate and amplitude both before and during bPAC stimulation ( Figures 7I and S6A-S6C) ; however, a significant light-evoked increase of mPSC amplitude persisted. Quantal size and release rate were affected, possibly as SVs with inactivated vATPase are not released [47] . BafA1 did not abolish further SV filling, most likely as a pre-established pH gradient remained. To probe whether mPSC amplitude regulation is achieved via vAChT, we inhibited it using vesamicol. Acute vesamicol application affected transmission before and during bPAC stimulation ( Figures 7J, S6B , and S6C), lowering basal mPSC rate, which, however, still increased in response to bPAC stimulation. Yet the mPSC amplitude increase was abolished by vesamicol. After the stimulus ended, mPSC amplitude was reduced ( Figure S6C ), possibly as newly formed SVs could not be filled properly. Thus, bPAC-induced neuropeptide release enhanced mPSC amplitudes via vAChT stimulation.
bPAC Stimulation Induces Larger SV Diameter Finally, we asked whether increased SV filling may cause SV swelling, as observed earlier [48] . We analyzed diameters of >16,000 SVs across all experiments ( Figure S7A ). To quantify (C and E) Mean ± SEM mPSC rate (C) and amplitudes (E) in 1,000 ms bins, normalized to before illumination, for bPAC-(blue) and ChR2-(gray) expressing neurons. Illumination period is indicated by blue and gray bars for bPAC-and ChR2-stimulated neurons, respectively. mean SV sizes, we first averaged the measured diameters per profile and then obtained a mean diameter per genotype and condition. Our measurements ($1 nm pixel size; manual outlining) allow determining SV diameter with ±2 nm accuracy. Hence, to reduce random error, only profiles with at least ten SVs were included. bPAC stimulation caused a small but significant increase in SV diameter (33.07 ± 1.46 to 34.48 ± 1.09 nm [$4 .1%] after 5 s; 5.1% at 30 s; Figure 7K ). The deduced volume increased by $14.5% (5 s; p < 0.001; assuming 3.4 nm membrane). Changes were similar for docked and cytosolic SVs. SVs were significantly smaller in unc-31/CAPS mutants (31.58 ± 0.88 nm), in which no change occurred in response to bPAC stimulation, supporting the hypothesis that SVs swell due to neuropeptide-increased vAChT activity. Thus, absence of neuropeptide signaling may result in smaller SVs and neuropeptide signaling may be a means to regulate SV diameter. In synapses that were photodepolarized by ChR2(C128S) for 1+8 s, no significant SV swelling occurred, consistent with the observed absence of DCV release ( Figures 2K, 4C, and 6F) . Last, we asked whether larger SV size could influence SV content independent of neuropeptide signaling. Mutants in UNC-11 (AP180) contain larger SVs [49] (Figure 7L : $39 nm, increasing volume by $80%); thus, we analyzed mPSCs in unc-11(e47). Whereas mPSC rate was largely reduced, the amplitude was not different from WT ( Figure 7M) . Thus, SV size does not per se affect neurotransmitter content. In sum, bPAC-induced 
DISCUSSION
cAMP signaling modulates neurotransmission, yet several cAMP-driven pathways and PKA complicate analysis of synaptic cAMP effects. Following acute optogenetic cAMP generation in cholinergic neurons, we analyzed the basis of bPAC-evoked behaviors by electrophysiology and ultrastructural analysis. Light-evoked cAMP generation increased SV priming and mobilization, which, upon depolarization, led to more SV release. In addition to SVs, cAMP also induced release of neuropeptidecontaining DCVs, and the released neuropeptides acted presynaptically to boost vAChT-mediated filling of SVs, thus increasing mPSC amplitudes.
We compared bPAC-and ChR2-evoked effects. ChR2 stimulation caused paralysis due to depolarization and release of (all) docked SVs, causing overall SV reduction and inducing bulk endocytosis. Yet, ChR2 caused neither DCV release nor mPSC amplitude increase. In contrast, bPAC stimulation enabled coordinated locomotion at elevated speed, exaggerated body bending, and slight contraction. bPAC did not cause depolarization but increased the rate of SV fusion events, thus potentiated but did not override network activity: whenever cholinergic neurons become active, increased cAMP enhances transmitter release via increased SV priming and mobilization, causing redistribution and depletion of SVs ( Figures S7B and S7C) .
DCVs are released by bPAC/cAMP signaling, demonstrated by (NLP-21::)Venus appearance in coelomocytes, and by DCV depletion. This was abolished in unc-31/CAPS mutants, where DCVs accumulated in/around synapses and where NLP-21::Venus levels were high in neuronal somata and processes. Whether cAMP effects on DCV release require concomitant depolarization remains to be shown. Elevated mPSC amplitudes evoked by bPAC stimulation are due to increased SV quantal content, as demonstrated by vAChT inhibition, and are in line with the rapidly observed increase in SV diameter. Increased mPSC amplitudes were not due to concomitant fusion of several SVs, as the effect was absent in ChR2 stimulation, which induces higher mPSC rates than bPAC. unc-31/CAPS mutants contained smaller SVs that were not enlarged by bPAC stimulation. Thus, released neuropeptides (induced by cAMP) and downstream signaling instructed SV filling by vAChT ( Figure S7D ). This signaling itself is not cAMP dependent, as otherwise bPAC stimulation should have bypassed the unc-31 mutant. Cholinergic neurons releasing neuropeptides may be distinct to the ones responding to them; yet, as the effect is present in dissected preparations, where distally released peptides would be largely diluted, this is unlikely. We can dismiss other scenarios explaining mPSC amplitude increase: first, we excluded effects of cAMP-evoked neuropeptide release on nAChR properties; and second, although reserve pool SVs may have higher ACh content and may be mobilized by cAMP, diameters of docked SVs and other SVs did not differ.
We propose the following model: cAMP/PKA signaling mobilizes SVs and increases their priming, resulting in increased fusion rate. cAMP also promotes discharge of neuropeptides that activate (auto-)receptors, increasing ACh loading. Charlie et al. [31] postulated that neuropeptides induce a cAMP pathway, augmenting release of small transmitters. In contrast, our data place UNC-31 downstream of cAMP/PKA effects and upstream of neuropeptide release, thereby increasing SV quantal content. cAMP signaling may enable synapses to undergo (homeostatic) changes in response to altered NMJ signaling or to adapt to different locomotion regimes. cAMPdependent synaptic facilitation changes behavior within seconds to tens of seconds. The intrinsic upstream trigger for cAMP signaling at cholinergic synapses, the neuropeptides released by motor neurons and their (auto-)receptors, remain to be identified. As DCVs are observed in mammalian cholinergic motor neurons [50] , neuropeptides may affect presynaptic facilitation also at the mammalian NMJ. 
